BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25119104)

  • 1. Preparation, characterisation and bioactivity evaluation of the inclusion complex formed between picoplatin and γ-cyclodextrin.
    Zhang JQ; Li K; Cong YW; Pu SP; Zhu HY; Xie XG; Jin Y; Lin J
    Carbohydr Res; 2014 Sep; 396():54-61. PubMed ID: 25119104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin.
    Zhang D; Zhang J; Jiang K; Li K; Cong Y; Pu S; Jin Y; Lin J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():501-8. PubMed ID: 26254603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of inclusion complex of epothilone A with cyclodextrins.
    Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
    Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
    Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE
    Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the complexation of gemfibrozil with gamma- and hydroxypropyl-gamma-cyclodextrins.
    Fernández L; Martínez-Ohárriz MC; Martín C; Vélaz I; Sánchez M; Zornoza A
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):943-8. PubMed ID: 18423939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex.
    Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G
    Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, Characterization, and Bioavailability of Host-Guest Inclusion Complex of Ginsenoside Re with Gamma-Cyclodextrin.
    Li H; Zhang G; Wang W; Chen C; Jiao L; Wu W
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of ursolic and oleanolic acids' antitumor activity by complexation with hydrophilic cyclodextrins.
    Oprean C; Mioc M; Csányi E; Ambrus R; Bojin F; Tatu C; Cristea M; Ivan A; Danciu C; Dehelean C; Paunescu V; Soica C
    Biomed Pharmacother; 2016 Oct; 83():1095-1104. PubMed ID: 27551755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an inclusion complex of ethyl benzoate with hydroxypropyl-β-cyclodextrin.
    Yuan C; Lu Z; Jin Z
    Food Chem; 2014; 152():140-5. PubMed ID: 24444918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical characterization of a ferulic acid/gamma-cyclodextrin inclusion complex.
    Anselmi C; Centini M; Ricci M; Buonocore A; Granata P; Tsuno T; Facino RM
    J Pharm Biomed Anal; 2006 Mar; 40(4):875-81. PubMed ID: 16239093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
    Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
    Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic investigation on the inclusion complex formation between amisulpride and γ-cyclodextrin.
    Negi JS; Singh S
    Carbohydr Polym; 2013 Feb; 92(2):1835-43. PubMed ID: 23399226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion complex of a Bcl-2 inhibitor with cyclodextrin: characterization, cellular accumulation, and in vivo antitumor activity.
    Zhang Z; Wu G; Gao J; Song T
    Mol Pharm; 2010 Aug; 7(4):1348-54. PubMed ID: 20550194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterisation of natamycin: gamma-cyclodextrin inclusion complex and its evaluation in vaginal mucoadhesive formulations.
    Cevher E; Sensoy D; Zloh M; Mülazimoğlu L
    J Pharm Sci; 2008 Oct; 97(10):4319-35. PubMed ID: 18288724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
    Yap KL; Liu X; Thenmozhiyal JC; Ho PC
    Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural evaluation of crystalline ternary γ-cyclodextrin complex.
    Higashi K; Ideura S; Waraya H; Moribe K; Yamamoto K
    J Pharm Sci; 2011 Jan; 100(1):325-33. PubMed ID: 20665507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.